KEGG   PATHWAY: mun05213
Entry
mun05213                    Pathway                                
Name
Endometrial cancer - Meriones unguiculatus (Mongolian gerbil)
Description
Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
Class
Human Diseases; Cancer: specific types
Pathway map
mun05213  Endometrial cancer
mun05213

Disease
H00026  Endometrial cancer
Organism
Meriones unguiculatus (Mongolian gerbil) [GN:mun]
Gene
110539539  Egfr; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
110541202  Tcf7l1; transcription factor 7-like 1 isoform X1 [KO:K04490]
110541705  Araf; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
110543001  Elk1; ETS domain-containing protein Elk-1 [KO:K04375]
110543676  Bak1; bcl-2 homologous antagonist/killer isoform X1 [KO:K14021]
110544642  [KO:K07828]
110544765  Nras; GTPase NRas [KO:K07828]
110545060  Casp9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
110545126  Tcf7l2; transcription factor 7-like 2 isoform X10 [KO:K04491]
110545779  Braf; serine/threonine-protein kinase B-raf isoform X8 [KO:K04365] [EC:2.7.11.1]
110545977  Cdh1; cadherin-1 [KO:K05689]
110546586  Cdkn1a; cyclin-dependent kinase inhibitor 1 isoform X2 [KO:K06625]
110546940  Ccnd1; G1/S-specific cyclin-D1 isoform X2 [KO:K04503]
110547073  Sos1; son of sevenless homolog 1 isoform X1 [KO:K03099]
110547825  Grb2; growth factor receptor-bound protein 2 [KO:K04364]
110547978  Mapk3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
110548394  Pik3cb; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
110548696  Axin1; axin-1 isoform X1 [KO:K02157]
110549145  Pik3r2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
110549622  Tcf7; transcription factor 7 isoform X6 [KO:K02620]
110550733  Ddb2; DNA damage-binding protein 2 [KO:K10140]
110550814  Raf1; RAF proto-oncogene serine/threonine-protein kinase isoform X2 [KO:K04366] [EC:2.7.11.1]
110551111  Apc; adenomatous polyposis coli protein isoform X1 [KO:K02085]
110551354  Apc2; adenomatous polyposis coli protein 2 isoform X2 [KO:K02085]
110551603  Bad; bcl2-associated agonist of cell death isoform X1 [KO:K02158]
110553013  Pdpk1; 3-phosphoinositide-dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
110553196  Egf; pro-epidermal growth factor [KO:K04357]
110553391  Lef1; lymphoid enhancer-binding factor 1 isoform X2 [KO:K04492]
110553683  Pik3r1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
110553796  Mapk1; mitogen-activated protein kinase 1 isoform X2 [KO:K04371] [EC:2.7.11.24]
110553931  Hras; GTPase HRas isoform X1 [KO:K02833]
110554082  Ctnna1; catenin alpha-1 isoform X1 [KO:K05691]
110554871  Ctnna3; catenin alpha-3 [KO:K05691]
110555127  Tp53; cellular tumor antigen p53 isoform X1 [KO:K04451]
110555390  Gsk3b; glycogen synthase kinase-3 beta isoform X4 [KO:K03083] [EC:2.7.11.26]
110555604  Gadd45b; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
110555605  Map2k2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
110555699  Foxo3; forkhead box protein O3 [KO:K09408]
110556252  Pik3ca; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
110556719  Akt2; RAC-beta serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
110556913  Sos2; son of sevenless homolog 2 isoform X1 [KO:K03099]
110558423  Gadd45a; growth arrest and DNA damage-inducible protein GADD45 alpha isoform X2 [KO:K04402]
110558913  Kras; GTPase KRas isoform X1 [KO:K07827]
110558966  Akt1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
110559000  Map2k1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
110559073  Gadd45g; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
110559312  Mlh1; DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
110559582  Ilk; integrin-linked protein kinase isoform X1 [KO:K06272] [EC:2.7.11.1]
110560064  Myc; myc proto-oncogene protein [KO:K04377]
110560658  Bax; apoptosis regulator BAX isoform X1 [KO:K02159]
110560727  Ctnna2; catenin alpha-2 isoform X1 [KO:K05691]
110561175  Pten; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
110561755  Ctnnb1; catenin beta-1 [KO:K02105]
110562952  Erbb2; receptor tyrosine-protein kinase erbB-2 [KO:K05083] [EC:2.7.10.1]
110563512  Pik3r3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
110563522  Axin2; axin-2 [KO:K04385]
110563772  Polk; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
110564898  Akt3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
110565112  Pik3cd; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
Compound
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Related
pathway
mun04010  MAPK signaling pathway
mun04012  ErbB signaling pathway
mun04060  Cytokine-cytokine receptor interaction
mun04110  Cell cycle
mun04115  p53 signaling pathway
mun04151  PI3K-Akt signaling pathway
mun04310  Wnt signaling pathway
mun04520  Adherens junction
KO pathway
ko05213   

DBGET integrated database retrieval system